Top

Journal of Assisted Reproduction and Genetics

Published in:

01-07-2008 | Case Report

A male phenotype (XY) hermaphrodite treated for seminoma, fathered a healthy child by IVF–ICSI technique

Authors: Faheem Zayed, Ibrahim Ghalayini, Ismail Matalka

Published in: Journal of Assisted Reproduction and Genetics | Issue 7/2008

Abstract

Objective

To report a successful delivery of a healthy infant fathered by an infertile 46, XY true hermaphrodite who suffered from a seminoma.

Design

Case report

Setting

IVF unit in University hospital

Patient(s)

Male 41 years (true hermaphrodite), his wife 35 years

Main Outcome Measures

Laboratory, pathology tests and ultrasound tests

Results

The above patient treated and cured from seminoma, the couple had in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) using frozen testicular sperm and had a healthy baby.

Conclusion

This is the first case report of a successful delivery of a healthy infant fathered by an infertile 46, XY true hermaphrodite who suffered from a seminoma. Once treated and cured, the couple had IVF and ICSI using frozen testicular sperm and had a healthy baby.

Krob G, Braun A, Kuhnle U. True hermaphroditism: geographical distribution, clinical findings, chromosomes and gonadal histology. Eur J Pediatr 1994;153:2–10. doi:10.1007/BF02000779.PubMedCrossRef

Blyth B, Duckett JW Jr. Gonadal differentiation: a review of the physiological process and influencing factors based on recent experimental evidence. J Urol 1991;145:689–94.PubMed

Gourlay WA, Johnson HW, Pantzar JT, McGillivray B, Crawford R, Nielsen WR. Gonadal tumours in disorders of sexual differentiation. Urology 1994;43:53–4. doi:10.1016/0090-4295(94)90251-8.CrossRef

Verp NS, Simpson JL. Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenet 1987;25:191. doi:10.1016/0165-4608(87)90180-4.PubMedCrossRef

Malik V, Gupta D, Meenu Gill M, Salvi AL. Seminoma in a male phenotype 46XX true hermaphrodite. Asian J Surg 2007;30(1):85–7.PubMed

German JL, Bearn AG, McGovern JH. Chromosomal studies of three hermaphrodites. Am J Med 1962;33:83–7. doi:10.1016/0002-9343(62)90279-6.PubMedCrossRef

Inatomi K, Oka S, Nomura Y, Ta N, Tsuhata K, Yoshida T, et al. Two cases of true hermaphrodite. Japn Soc Ob Gyn 1973;25:720. in Japanese.

Manba S, Adachi T, Narita S, Nakanishi O, Ishihara N. The pregnancy and delivery from true hermaphrodite. Japn Fertil Steril 1971;16:110. in Japanese.

Møller H, Skakkebaek NE. Risk of testicular cancer in subfertile men: case–control study. BMJ 1999;318:599.

10.

Raman JD, Nobert CF, Goldstein M. Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis. J Urol 2005;174:1819–22. doi:10.1097/01.ju.0000177491.98461.aa.PubMedCrossRef

11.

Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001;16:972–8. doi:10.1093/humrep/16.5.972.PubMedCrossRef

12.

Schlegel PN. Testicular sperm extraction: microdissection improves sperm yield with minimal tissue excision. Hum Reprod 1999;14:131–5. doi:10.1093/humrep/14.1.131.PubMedCrossRef

13.

Carmignani L, Gadda F, Gazzano G, Ragni G, Paffoni A, Rocco F, et al. Testicular sperm extraction in cancerous testicle in patients with azoospermia: a case report. Hum Reprod 2007;22(4):1068–72.PubMedCrossRef

14.

Novero V Jr, Goossens A, Tournaye H, Silber S, Van Steirteghem AC, Devroey P. Seminoma discovered in two males undergoing successful testicular sperm extraction for intracytoplasmic sperm injection. Fertil Steril 1996;65:1051–4.PubMed

15.

Res U, Res P, Kastelic D, Stanovik M, Kmetec A, Merlo M. Birth after treatment of a male with seminoma and azoospermia with cryopreserved-thawed testicular tissue. Hum Reprod 2000;15(4):861–4. doi:10.1093/humrep/15.4.861.PubMedCrossRef

16.

Botchan A, Hauser R, Yogev L, et al. Testicular cancer and spermatogenesis. Hum Reprod 1997;12:755–8. doi:10.1093/humrep/12.4.755.PubMedCrossRef

17.

Kohn FM, Schroeder P, Weidner W, Montag M, van del Ven H, Schill WB. Testicular sperm extraction in a patient with metachronous bilateral testicular cancer. Hum Reprod 2001;16:2343–6.PubMed

18.

Gundy S, Baki M, Bodrogi I, Czeizl A. Persistence of chromosomal aberration in blood lymphocytes of testicular cancer patients. Oncology 1992;49:376–80.PubMedCrossRef

19.

Sugawara N, Tokunaga Y, Maeda M, Komaba R, Araki Y. A successful pregnancy outcome using frozen testicular sperm from a chimeric infertile male with a 46, XX/46, XY karyotype: case report. Hum Reprod 2005;20(1):147–8. doi:10.1093/humrep/deh587.PubMedCrossRef

Title: A male phenotype (XY) hermaphrodite treated for seminoma, fathered a healthy child by IVF–ICSI technique
Authors: Faheem Zayed
Ibrahim Ghalayini
Ismail Matalka
Publication date: 01-07-2008
Publisher: Springer US
Published in: Journal of Assisted Reproduction and Genetics / Issue 7/2008
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI: https://doi.org/10.1007/s10815-008-9234-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A male phenotype (XY) hermaphrodite treated for seminoma, fathered a healthy child by IVF–ICSI technique

Abstract

Objective

Design

Setting

Patient(s)

Main Outcome Measures

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Design

Setting

Patient(s)

Main Outcome Measures

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 7/2008

Viability of frozen-thawed human embryos with one–two blastomeres lysis

Human oocyte and ovarian tissue cryopreservation and its application

Preimplantation HLA haplotyping using tri-, tetra-, and pentanucleotide short tandem repeats for HLA matching

Short gamete co-incubation during in vitro fertilization decreases the fertilization rate and does not improve embryo quality: a prospective auto controlled study

Ovarian reserve evaluation: state of the art

Affordable ART for developing countries: a cost benefit comparison of low dose stimulation versus high dose GnRH antagonist protocol